查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601276

研究抗体和试剂市场：按产品、技术、适应症、应用和最终用户 - 2025-2030 年全球预测

Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，研究用抗体和试剂市值为165.4亿美元，预计到2024年将达到185.5亿美元，复合年增长率为12.02%，到2030年将达到366.2亿美元。

研究抗体和试剂包括多种用于在免疫组织化学、流式细胞技术和西方印渍术等应用中检测蛋白质和其他分子的产品。这些工具对于生物医学研究、诊断和药物开发至关重要。对抗体和试剂的需求源于它们在识别疾病生物标记、制定治疗策略和确保准确的实验结果方面的关键作用。这些产品最终用于学术研究机构、生物技术公司、製药公司、临床实验室和委託研究组织。最近的市场成长是由慢性病的增加、蛋白质组学和基因组学的进步以及生物技术公司研发投资的增加所推动的。个人化医疗领域是一个特殊的机会，该领域对客製化诊断和治疗解决方案的需求正在迅速增长。公司可以利用这一点，开发更具特异性且在检测中产生更少背景噪音的创新试剂。然而，市场扩张面临挑战，包括生产抗体的高成本、严格的监管要求以及需要高技能人员执行和解释复杂的实验。此外，批次间差异和抗体交叉反应等问题也构成了主要障碍。为了推动业务成长，公司应专注于开发具有更高特异性和可重复性的重组和单株抗体。不断发展的数位病理学领域也有潜力，其中试剂和先进成像技术的整合有望简化工作流程并提高诊断准确性。市场竞争激烈，许多老牌和新兴企业不断创新以赢得市场占有率。优先提供高品质、经济高效和多功能解决方案的公司将在这个不断变化的环境中取得成功。

主要市场统计
基准年[2023] 165.4亿美元
预测年份 [2024] 185.5亿美元
预测年份 [2030] 366.2亿美元
复合年增长率（%） 12.02%

市场动态：快速发展的研究抗体和试剂市场的关键市场洞察

研究抗体和试剂市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 製药和生物製药公司的研究活动增加
    • 蛋白质体学和基因组学研究日益普及
    • 个人化医疗和蛋白质治疗中研究性抗体和试剂的新趋势
  • 市场限制因素
    • 抗体开发过程成本高
  • 市场机会
    • 加大研究抗体和试剂的研发力道
    • 越来越关注寻找新的生物标誌物
  • 市场挑战
    • 对研究抗体和试剂品质以及结果缺乏可重复性的担忧

波特五力战略工具驾驭研究性抗体与试剂市场

波特的五力框架是了解研究抗体和试剂市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解研究抗体和试剂市场的外部影响

外部宏观环境因素在塑造研究抗体和试剂市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解研究抗体/试剂市场的竞争状况

研究抗体和试剂市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV定位矩阵研究抗体和试剂市场供应商的绩效评估

FPNV定位矩阵是评估研究抗体和试剂市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药和生物製药公司的研究活动增加
      • 蛋白质体学和基因组学研究日益普及
      • 个人化医疗和蛋白质治疗中研究性抗体和试剂的新趋势
    • 抑制因素
      • 抗体开发过程高成本
    • 机会
      • 加强研究用抗体和试剂的研发
      • 人们越来越关注新生物标誌物的发现
    • 任务
      • 对研究抗体/试剂品质和缺乏可重复结果的担忧
  • 市场区隔分析
    • 产品：抗体在目标蛋白的检测和定量中变得越来越流行
    • 技术：在流式细胞技术中更多地使用研究抗体和试剂进行免疫表型分析
    • 适应症：扩大在研抗体和试剂在感染疾病病原体鑑定上的应用
    • 应用：越来越多地使用研究性抗体和试剂来开发针对特定治疗标靶的药物
    • 最终用户：扩大在製药和生物技术公司中研究抗体和试剂的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 研究抗体与试剂市场：副产品

  • 抗体
    • 单株抗体
    • 多株抗体
    • 重组抗体
  • 试剂
    • 缓衝
    • 酵素
    • 稳定剂
    • 媒体与血清
    • 探测
    • 溶剂
    • 染料

第七章 研究抗体与试剂市场：依技术分类

  • 酵素免疫分析法
  • 流式细胞技术
  • 萤光
  • 免疫组织化学
  • 免疫沉淀分析法
  • 蛋白质印迹法

第八章 研究用抗体和试剂市场（按适应症）

  • 免疫学
  • 感染疾病
  • 神经生物学
  • 肿瘤学
  • 干细胞

第九章研究抗体与试剂市场：依应用分类

  • 药物开发
  • 基因组学
  • 蛋白质体学

第 10 章 研究抗体与试剂市场：依最终用户

  • 学术/研究机构
  • 合约调查机构
  • 製药/生物技术

第十一章美洲抗体和试剂市场研究

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太研究抗体与试剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第13章：欧洲、中东和非洲研究抗体和试剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 金斯瑞扩大试剂服务范围，包括环状RNA和脂质奈米颗粒製剂
    • Bio-Rad Laboratories 扩大了与 Starbrite 染料结合的抗体标记物的阵容
    • 丹纳赫收购 Abcam
    • ERS Genomics 与 Santa Cruz Biotechnology 签署 CRISPR/Cas9 授权协议
    • Teknova 宣布开设新的 GMP 认证工厂，以提高自订高品质生命科学试剂的生产能力
    • Lonza 集团收购 Synafix 以加强抗体药物复合体产品
    • BD 和 A*STAR 合作推进流式细胞技术中的超高维分析用于免疫学研究
    • Teknova 和 Sartorius 旨在解决 AAV 生物加工中的关键痛点
    • Biotechne 和 Cell Signaling Technology 宣布合作检验简单的西方抗体
    • Cytek Biosciences, Inc. 与 Bio-Rad Laboratories, Inc. 合作扩大试剂产品组合

公司名单

  • Dovetail Genomics LLC
  • Tosoh Corporation
  • Randox Laboratories Ltd.
  • Enzo Life Sciences, Inc.
  • GenScript Biotech Corporation
  • BASF SE
  • Bio-Rad Laboratories, Inc.
  • Alpha Teknova, Inc.
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
  • ImmunoPrecise Antibodies Ltd.
  • Charles River Laboratories International, Inc.
  • LifeSpan BioSciences, Inc.
  • Cell Signaling Technology, Inc.
  • Abbott Laboratories
  • bioMerieux SA
  • Atlas Antibodies AB
  • FUJIFILM Holdings Corporation
  • Santa Cruz Biotechnology, Inc.
  • QIAGEN NV
  • Tokyo Chemical Industry Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • Lonza Group Ltd.
  • Sino Biological, Inc.
  • PerkinElmer, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Rockland Immunochemicals, Inc.
  • Avantor, Inc.
  • Danaher Corporation
  • Leinco Technologies, Inc.
  • Agilent Technologies Inc.
  • Bio-Techne Corporation
  • Honeywell International Inc.
  • Illumia, Inc.
  • Omega Bio-tek, Inc.
  • LobaChemie Pvt. Ltd.
Product Code: MRR-0D217D5AE090

The Research Antibodies & Reagents Market was valued at USD 16.54 billion in 2023, expected to reach USD 18.55 billion in 2024, and is projected to grow at a CAGR of 12.02%, to USD 36.62 billion by 2030.

The scope of research antibodies and reagents encompasses a diverse array of products used for detecting proteins and other molecules in applications such as immunohistochemistry, flow cytometry, and western blotting. These tools are indispensable in biomedical research, diagnostics, and drug development. The necessity of antibodies and reagents stems from their crucial role in identifying disease biomarkers, developing therapeutic strategies, and ensuring accurate experimental outcomes. These products find end-use in academic research institutions, biotech and pharmaceutical companies, clinical laboratories, and contract research organizations. Recent market growth is driven by the rising prevalence of chronic diseases, advancements in proteomics and genomics, and the increasing investment in R&D by biotech firms. A notable opportunity lies in the personalized medicine sector, where the demand for tailored diagnostic and therapeutic solutions is surging. Companies can capitalize on this by developing innovative reagents that provide greater specificity and lower background noise in assays. However, market expansion faces challenges such as the high cost of antibody production, stringent regulatory requirements, and the need for highly skilled personnel to conduct and interpret complex experiments. Furthermore, issues such as batch-to-batch variability and cross-reactivity of antibodies pose significant hurdles. To foster business growth, companies should focus on developing recombinant and monoclonal antibodies with enhanced specificity and reproducibility. There is also potential in the growing field of digital pathology, where integrating reagents with advanced imaging technologies can streamline workflow efficiencies and improve diagnostic accuracies. The nature of the market is highly competitive, characterized by the presence of numerous established and emerging players constantly innovating to capture market share. Companies that prioritize offering high-quality, cost-effective, and versatile solutions are better positioned to thrive in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 16.54 billion
Estimated Year [2024] USD 18.55 billion
Forecast Year [2030] USD 36.62 billion
CAGR (%) 12.02%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Research Antibodies & Reagents Market

The Research Antibodies & Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research activities by pharmaceutical and biopharmaceutical companies
    • Rising popularity of proteomics and genomics research
    • Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
  • Market Restraints
    • High cost of antibody development processes
  • Market Opportunities
    • Increasing R&D in research antibodies & reagents
    • Rising focus on discovering novel biomarkers
  • Market Challenges
    • Quality concerns and a lack of reproducible results of research antibodies & reagents

Porter's Five Forces: A Strategic Tool for Navigating the Research Antibodies & Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Research Antibodies & Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Research Antibodies & Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Research Antibodies & Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Research Antibodies & Reagents Market

A detailed market share analysis in the Research Antibodies & Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Research Antibodies & Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Research Antibodies & Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Dovetail Genomics LLC, Tosoh Corporation, Randox Laboratories Ltd., Enzo Life Sciences, Inc., GenScript Biotech Corporation, BASF SE, Bio-Rad Laboratories, Inc., Alpha Teknova, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ImmunoPrecise Antibodies Ltd., Charles River Laboratories International, Inc., LifeSpan BioSciences, Inc., Cell Signaling Technology, Inc., Abbott Laboratories, bioMerieux S.A., Atlas Antibodies AB, FUJIFILM Holdings Corporation, Santa Cruz Biotechnology, Inc., QIAGEN N.V., Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific, Inc., Lonza Group Ltd., Sino Biological, Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Rockland Immunochemicals, Inc., Avantor, Inc., Danaher Corporation, Leinco Technologies, Inc., Agilent Technologies Inc., Bio-Techne Corporation, Honeywell International Inc., Illumia, Inc., Omega Bio-tek, Inc., and LobaChemie Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Research Antibodies & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibodies and Reagent. The Antibodies is further studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Reagent is further studied across Buffers, Enzymes, Fixatives, Media & Sera, Probes, Solvents, and Stains & Dyes.
  • Based on Technology, market is studied across Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting.
  • Based on Indication, market is studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells.
  • Based on Application, market is studied across Drug Development, Genomics, and Proteomics.
  • Based on End User, market is studied across Academic & Research Institutions, Contract Research Organizations, and Pharmaceutical & Biotechnology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
      • 5.1.1.2. Rising popularity of proteomics and genomics research
      • 5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of antibody development processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D in research antibodies & reagents
      • 5.1.3.2. Rising focus on discovering novel biomarkers
    • 5.1.4. Challenges
      • 5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
    • 5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
    • 5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
    • 5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
    • 5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Research Antibodies & Reagents Market, by Product

  • 6.1. Introduction
  • 6.2. Antibodies
    • 6.2.1. Monoclonal Antibodies
    • 6.2.2. Polyclonal Antibodies
    • 6.2.3. Recombinant Antibodies
  • 6.3. Reagent
    • 6.3.1. Buffers
    • 6.3.2. Enzymes
    • 6.3.3. Fixatives
    • 6.3.4. Media & Sera
    • 6.3.5. Probes
    • 6.3.6. Solvents
    • 6.3.7. Stains & Dyes

7. Research Antibodies & Reagents Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-linked Immunosorbent Assay
  • 7.3. Flow Cytometry
  • 7.4. Immunofluorescence
  • 7.5. Immunohistochemistry
  • 7.6. Immunoprecipitation
  • 7.7. Western Blotting

8. Research Antibodies & Reagents Market, by Indication

  • 8.1. Introduction
  • 8.2. Immunology
  • 8.3. Infectious Diseases
  • 8.4. Neurobiology
  • 8.5. Oncology
  • 8.6. Stem Cells

9. Research Antibodies & Reagents Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Development
  • 9.3. Genomics
  • 9.4. Proteomics

10. Research Antibodies & Reagents Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutions
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology

11. Americas Research Antibodies & Reagents Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Research Antibodies & Reagents Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Research Antibodies & Reagents Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
    • 14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
    • 14.3.3. Danaher to Acquire Abcam plc
    • 14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
    • 14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
    • 14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
    • 14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
    • 14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
    • 14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios

Companies Mentioned

  • 1. Dovetail Genomics LLC
  • 2. Tosoh Corporation
  • 3. Randox Laboratories Ltd.
  • 4. Enzo Life Sciences, Inc.
  • 5. GenScript Biotech Corporation
  • 6. BASF SE
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Alpha Teknova, Inc.
  • 9. Cardinal Health, Inc.
  • 10. Becton, Dickinson and Company
  • 11. ImmunoPrecise Antibodies Ltd.
  • 12. Charles River Laboratories International, Inc.
  • 13. LifeSpan BioSciences, Inc.
  • 14. Cell Signaling Technology, Inc.
  • 15. Abbott Laboratories
  • 16. bioMerieux S.A.
  • 17. Atlas Antibodies AB
  • 18. FUJIFILM Holdings Corporation
  • 19. Santa Cruz Biotechnology, Inc.
  • 20. QIAGEN N.V.
  • 21. Tokyo Chemical Industry Co., Ltd.
  • 22. Thermo Fisher Scientific, Inc.
  • 23. Lonza Group Ltd.
  • 24. Sino Biological, Inc.
  • 25. PerkinElmer, Inc.
  • 26. F. Hoffmann-La Roche Ltd.
  • 27. Merck KGaA
  • 28. Rockland Immunochemicals, Inc.
  • 29. Avantor, Inc.
  • 30. Danaher Corporation
  • 31. Leinco Technologies, Inc.
  • 32. Agilent Technologies Inc.
  • 33. Bio-Techne Corporation
  • 34. Honeywell International Inc.
  • 35. Illumia, Inc.
  • 36. Omega Bio-tek, Inc.
  • 37. LobaChemie Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. RESEARCH ANTIBODIES & REAGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. RESEARCH ANTIBODIES & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. RESEARCH ANTIBODIES & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESEARCH ANTIBODIES & REAGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RESEARCH ANTIBODIES & REAGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FIXATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (US